home / stock / sbph / sbph news


SBPH News and Press, Spring Bank

Stock Information

Company Name: Spring Bank
Stock Symbol: SBPH
Market: NASDAQ

Menu

SBPH SBPH Quote SBPH Short SBPH News SBPH Articles SBPH Message Board
Get SBPH Alerts

News, Short Squeeze, Breakout and More Instantly...

SBPH - F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals

F-star Therapeutics Completes Combination with Spring Bank Pharmaceuticals To Commence Trading November 23 on Nasdaq: FSTX PR Newswire CAMBRIDGE, England and CAMBRIDGE, Mass., Nov. 20, 2020 CAMBRIDGE, England and CAMBRIDGE, Mass. , Nov. 20, 2020 /PRN...

SBPH - CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics 1-for-4 Reverse Stock Split to be Effective November 23, 2020 PR Newswire HOPKINTON, Mass., Nov. 20, 2020 HOPKINTON, Mass. , Nov. 20, 2020 /PRNe...

SBPH - Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

HOPKINTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, announced that at its special meeting of stock...

SBPH - Spring Bank Pharmaceuticals intends to declare a special dividend

Spring Bank Pharmaceuticals (SBPH) intends to roll out a special dividend with a expected record date to be November 19, 2020.The special dividend is expected to be payable immediately prior to the closing of Spring Bank’s proposed combination with F-star Therapeutics.Dividend amo...

SBPH - Spring Bank Pharmaceuticals Announces Special Dividend of Contingent Value Rights

HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring Bank”), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced that its board of directors in...

SBPH - Spring Bank Announces Poster Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

HOPKINTON, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced an upcoming trial-in-progress poster presentation for SB 112...

SBPH - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors head into next week with a few October surprises already in the books. Stimulus drama and further developments...

SBPH - 5 Penny Stocks To Watch With Recent & Upcoming Biotech Events

Penny Stocks To Watch If Biotech Is Your Focus This Week Another week and another round of penny stocks to watch. One of the top sectors this year that has produced some of the biggest winners: Biotechnology. There’s no secret that coronavirus vaccine stocks have been a prime...

SBPH - SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm - MNTA, SBPH, VAR

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to John...

SBPH - Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.  Moore Kuehn may ultimately s...

Next 10